These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 3777262)

  • 21. Follow-up study of control subjects with lactate- and isoproterenol-induced panic attacks.
    Balon R; Pohl R; Yeragani VK; Rainey JM; Berchou R
    Am J Psychiatry; 1988 Feb; 145(2):238-41. PubMed ID: 3341469
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vulnerability to sodium lactate in panic disorder patients given cognitive-behavioral therapy.
    Shear MK; Fyer AJ; Ball G; Josephson S; Fitzpatrick M; Gitlin B; Frances A; Gorman J; Liebowitz M; Klein DF
    Am J Psychiatry; 1991 Jun; 148(6):795-7. PubMed ID: 2035724
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Improved cognition in Alzheimer's disease with short-term D-cycloserine treatment.
    Tsai GE; Falk WE; Gunther J; Coyle JT
    Am J Psychiatry; 1999 Mar; 156(3):467-9. PubMed ID: 10080566
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lactate-induced panic in primary affective disorder.
    Cowley DS; Dager SR; Dunner DL
    Am J Psychiatry; 1986 May; 143(5):646-8. PubMed ID: 3963256
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical pharmacokinetics of physostigmine in patients with Alzheimer's disease.
    Asthana S; Greig NH; Hegedus L; Holloway HH; Raffaele KC; Schapiro MB; Soncrant TT
    Clin Pharmacol Ther; 1995 Sep; 58(3):299-309. PubMed ID: 7554703
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Behavioral effects of a synthetic corticotropin 4-9 analog in patients with depression and patients with Alzheimer's disease.
    Heuser I; Heuser-Link M; Gotthardt U; Grasser A; Holsboer F
    J Clin Psychopharmacol; 1993 Jun; 13(3):171-4. PubMed ID: 8394847
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A retrospective chart review of the tolerability and efficacy of intravenous immunoglobulin in the treatment of Alzheimer's disease.
    Devi G; Schultz S; Khosrowshahi L; Agnew A; Olali E; Devi G
    J Am Geriatr Soc; 2008 Apr; 56(4):772-4. PubMed ID: 18380688
    [No Abstract]   [Full Text] [Related]  

  • 28. [Tacrine: progress in treatment of Alzheimer's disease?].
    Kurz A; Marquard R; Mösch D
    Z Gerontol Geriatr; 1995; 28(3):163-8. PubMed ID: 7664190
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Presentation and stability of cognitive and noncognitive symptom patterns in patients with Alzheimer's disease. Disease course over a two-year period under constant treatment conditions with rivastigmine].
    Wobrock T; Retz-Junginger P; Retz W; Supprian T; Rösler M
    Fortschr Neurol Psychiatr; 2003 Apr; 71(4):199-204. PubMed ID: 12677553
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nicotine evoked improvement in learning and memory is mediated through NPY Y1 receptors in rat model of Alzheimer's disease.
    Rangani RJ; Upadhya MA; Nakhate KT; Kokare DM; Subhedar NK
    Peptides; 2012 Feb; 33(2):317-28. PubMed ID: 22266216
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Tacrine in Alzheimer's disease].
    López de Munain A
    Rev Neurol; 1997 Jul; 25 Suppl 1():S70-2. PubMed ID: 9280671
    [No Abstract]   [Full Text] [Related]  

  • 32. Specificity of lactate infusions in social phobia versus panic disorders.
    Liebowitz MR; Fyer AJ; Gorman JM; Dillon D; Davies S; Stein JM; Cohen BS; Klein DF
    Am J Psychiatry; 1985 Aug; 142(8):947-50. PubMed ID: 4025591
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nicotine and dementia.
    Grant DJ; McMurdo ME; Balfour DJ
    Br J Psychiatry; 1989 Nov; 155():716. PubMed ID: 2611607
    [No Abstract]   [Full Text] [Related]  

  • 34. Nicotine intake and Alzheimer's disease.
    Pearson RC; Mullan M; Hardy J; Harrison PJ
    BMJ; 1991 Aug; 303(6798):361. PubMed ID: 1912783
    [No Abstract]   [Full Text] [Related]  

  • 35. Health news. The sleeper syndrome.
    Harv Health Lett; 2001 Jan; 26(3):6. PubMed ID: 11137959
    [No Abstract]   [Full Text] [Related]  

  • 36. Relations among acute and chronic nicotine administration, short-term memory, and tactics of data analysis.
    Kangas BD; Branch MN
    J Exp Anal Behav; 2012 Sep; 98(2):155-67. PubMed ID: 23008520
    [TBL] [Abstract][Full Text] [Related]  

  • 37. TC-1734: an orally active neuronal nicotinic acetylcholine receptor modulator with antidepressant, neuroprotective and long-lasting cognitive effects.
    Gatto GJ; Bohme GA; Caldwell WS; Letchworth SR; Traina VM; Obinu MC; Laville M; Reibaud M; Pradier L; Dunbar G; Bencherif M
    CNS Drug Rev; 2004; 10(2):147-66. PubMed ID: 15179444
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sexually dimorphic effect of an acute smoking manipulation on skin resistance but not on heart-rate during a cognitive verbal task.
    Furedy JJ; Algan O; Vincent A; Demirgoren S; Pogun S
    Integr Physiol Behav Sci; 1999; 34(4):219-26. PubMed ID: 10791605
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nicotinic acetylcholine receptor (nACh-R) agonist-induced changes in brain monoamine turnover in mice.
    Tani Y; Saito K; Tsuneyoshi A; Imoto M; Ohno T
    Psychopharmacology (Berl); 1997 Feb; 129(3):225-32. PubMed ID: 9084060
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A microdialysis study of the effects of the nicotinic agonist RJR-2403 on cortical release of acetylcholine and biogenic amines.
    Summers KL; Lippiello P; Giacobini E
    Neurochem Res; 1996 Oct; 21(10):1181-6. PubMed ID: 8923478
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.